Qing Yin

1.9k citations
27 papers · 1.3k indexed · 1 hit paper · h-index 17
Topics
Ubiquitin and proteasome pathways (6 papers)Melanoma and MAPK Pathways (4 papers)Cancer-related molecular mechanisms research (4 papers)

In The Last Decade

Qing Yin

25 papers receiving 1.3k citations

Hit Papers

RAF-MEK-ERK pathway in cancer evolution and treatment2021202620222024202150100150200250

Peers

Qing Yin
Comparison fields: 5 of 96
  • Molecular Biology 718
  • Cancer Research 221
  • Oncology 187
  • Immunology 175
  • Pulmonary and Respiratory Medicine 109
Replace Linlin Sun with:
Linlin Sun China
Cesáreo Roncero Spain
Zully Pedrozo Chile
Lei Sun China
Lucian Soane United States
Stéphanie Barrère‐Lemaire France
Fang Yao China
Elisabeth Berber United States
Lin Ma China
Mayu Morita Japan
Qing Yin relative to Linlin Sun China Linlin Sun's profile →
Citations per field
00.5×1.5×2.1×
Linlin Sun · 1×
Citations per year

Countries citing papers authored by Qing Yin

Since Specialization
Citations

This map shows the geographic impact of Qing Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Yin more than expected).

Fields of papers citing papers by Qing Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Yin. The network helps show where Qing Yin may publish in the future.

Co-authorship network of co-authors of Qing Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Yin. A scholar is included among the top collaborators of Qing Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Yin. Qing Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 4
5 13
6 7
7
RAF-MEK-ERK pathway in cancer evolution and treatmentbreakdown →
292
8 86
9 4
10 38
11 16
12 62
13 74
14 25
15 37
16 2
17 214
18 131
19 17
20 18

About Qing Yin

Qing Yin is a scholar working on Cancer Research, Molecular Biology and Developmental Neuroscience, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Melanoma and MAPK Pathways (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (221 citations), Developmental Neuroscience (58 citations) and Molecular Biology (718 citations). Qing Yin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lixin Wan, Rahim Ullah, Jing Zhang, Shuangxi Zhang, Zhi Hou, He Zhu, Wei Duan, Chunqing Zhang, Yuping Zhang and Chen Huang. Their work appears in journals such as Nature Communications, Blood and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026